Agitated Solutions receives IND application clearance from US FDA to begin phase 3 clinical trial for its novel contrast agent, ASI-02: St. Paul, Minn. Friday, April 11, 2025, 15: ...

The U.S. Food and Drug Administration (FDA) has cleared Agitated Solutions, Incorporated (ASI)’s Investigational New Drug (IND) application for its novel contrast agent, ASI-02, enabling the ...

PDA, patent ductus arteriosus; MBTS, modified Blalock-Taussig shunt; AAO, ascending aorta; DA, descending aorta; RSA, right subclavian artery; RCCA, right common carotid artery; RPA, right pulmonary ...

Objectives Patients with Ebstein’s anomaly of the tricuspid valve (EA) are at risk of tachyarrhythmia, congestive heart failure and sudden cardiac death. We sought to determine the value of ...

Some of these complications include cardiac arrest/sudden death, right ventricular failure (RVF), syncope, hypoxemic respiratory failure, arrhythmias, hemoptysis, pulmonary embolism, chest pain/left ...

Varanasi: An 18-year-old boy with a complex congenital cardiac abnormality was operated on successfully in the ...

Its incidence in the general population is 0.5%. In cardiac surgery patients, it is suspected when using the left subclavian vein or left internal jugular vein for central venous catheter or ...

A promising application of nitinol’s shape memory properties is under development by heart failure startup Adona Medical, which is working on a heart shunt device that can be adjusted for variable ...

Dark leafy greens, fish, whole grains, low fat dairy products, and some carb sources may help manage diabetes and lower your risk of heart disease. Diabetes is a health condition in which the horm ...

A unique subset of cardiac fibroblasts expressing CD248 orchestrates immune–fibroblast crosstalk, promoting chronic cardiac fibrosis and dysfunction after ischemia–reperfusion injury ...